Corcept Therapeutics (CORT) Investor Alert: April 21 Deadline Approaches in Securities Fraud Case
Investors Who Purchased CORCEPT Stock May Have Limited Time to Act Investors who purchased shares of Corcept Therapeutics Incorporated may have only days remaining to take action as a key deadline approaches in a pending securities fraud class action. According to recently filed litigation, the case alleges that Corcept and certain executives made materially misleading [...]


















